These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29978586)

  • 1. Retrospective analysis of the usefulness of a protocol with high-dose methotrexate in polymyalgia rheumatica: Results of a single-center cohort of 100 patients.
    Quartuccio L; Gregoraci G; Isola M; De Vita S
    Geriatr Gerontol Int; 2018 Sep; 18(9):1410-1414. PubMed ID: 29978586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of polymyalgia rheumatica patients treated with methotrexate and steroids.
    Cimmino MA; Salvarani C; Macchioni P; Gerli R; Bartoloni Bocci E; Montecucco C; Caporali R;
    Clin Exp Rheumatol; 2008; 26(3):395-400. PubMed ID: 18578959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methotrexate therapy of polymyalgia rheumatica].
    Wagener P
    Z Rheumatol; 1995; 54(6):413-6. PubMed ID: 8578892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of polymyalgia rheumatica: a systematic review.
    Hernández-Rodríguez J; Cid MC; López-Soto A; Espigol-Frigolé G; Bosch X
    Arch Intern Med; 2009 Nov; 169(20):1839-50. PubMed ID: 19901135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?
    van der Veen MJ; Dinant HJ; van Booma-Frankfort C; van Albada-Kuipers GA; Bijlsma JW
    Ann Rheum Dis; 1996 Apr; 55(4):218-23. PubMed ID: 8733437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phase (PMR MODE): study protocol for a multicenter double-blind placebo controlled trial.
    Marsman DE; Bolhuis TE; den Broeder N; den Broeder AA; van der Maas A
    Trials; 2022 Apr; 23(1):318. PubMed ID: 35428320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial.
    Caporali R; Cimmino MA; Ferraccioli G; Gerli R; Klersy C; Salvarani C; Montecucco C;
    Ann Intern Med; 2004 Oct; 141(7):493-500. PubMed ID: 15466766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica: a systematic literature review informing the 2015 European League Against Rheumatism/American College of Rheumatology recommendations for the management of polymyalgia rheumatica.
    Dejaco C; Singh YP; Perel P; Hutchings A; Camellino D; Mackie S; Matteson EL; Dasgupta B
    Ann Rheum Dis; 2015 Oct; 74(10):1808-17. PubMed ID: 26359489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Permanent Discontinuation of Glucocorticoids in Polymyalgia Rheumatica Is Uncommon but May Be Enhanced by Amino Bisphosphonates.
    Giollo A; Rossini M; Bettili F; Ghellere F; Fracassi E; Idolazzi L; Gatti D; Viapiana O
    J Rheumatol; 2019 Mar; 46(3):318-322. PubMed ID: 30385701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of Methotrexate in the Reduction of Relapses and Recurrences in Polymyalgia Rheumatica: An Observational Study.
    de la Torre ML; Rodríguez AM; Pisoni CN
    J Clin Rheumatol; 2020 Oct; 26(7S Suppl 2):S213-S217. PubMed ID: 32453210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study.
    Ferraccioli G; Salaffi F; De Vita S; Casatta L; Bartoli E
    J Rheumatol; 1996 Apr; 23(4):624-8. PubMed ID: 8730115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of add-on methotrexate in polymyalgia rheumatica patients flaring on glucocorticoids tapering: a retrospective study.
    Marsman D; Bolhuis T; Broeder ND; van den Hoogen F; den Broeder A; van der Maas A
    Rheumatol Int; 2021 Mar; 41(3):611-616. PubMed ID: 33486552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy.
    Mori S; Koga Y
    Clin Rheumatol; 2016 May; 35(5):1367-75. PubMed ID: 24803231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of glucocorticoid-free remission in patients with polymyalgia rheumatica treated with prednisolone.
    Hattori K; Hirano Y; Kojima T
    Int J Rheum Dis; 2020 Nov; 23(11):1581-1586. PubMed ID: 32996694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of polymyalgia rheumatica and large vessel vasculitis].
    Hellmich B
    Internist (Berl); 2016 Nov; 57(11):1069-1078. PubMed ID: 27631531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of methotrexate in polymyalgia rheumatica.
    Feinberg HL; Sherman JD; Schrepferman CG; Dietzen CJ; Feinberg GD
    J Rheumatol; 1996 Sep; 23(9):1550-2. PubMed ID: 8877923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
    Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
    Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate for treating polymyalgia rheumatica: A meta-analysis of randomized controlled trials.
    Song GG; Lee YH
    Int J Clin Pharmacol Ther; 2021 May; 59(5):366-371. PubMed ID: 33480843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparable Rates of Glucocorticoid-Associated Adverse Events in Patients With Polymyalgia Rheumatica and Comorbidities in the General Population.
    Shbeeb I; Challah D; Raheel S; Crowson CS; Matteson EL
    Arthritis Care Res (Hoboken); 2018 Apr; 70(4):643-647. PubMed ID: 28704600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on treatment of polymyalgia rheumatica.
    Camellino D; Dejaco C
    Reumatismo; 2018 Mar; 70(1):59-66. PubMed ID: 29589404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.